| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-07 |
| mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |